Drug class

RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides

The phrase "RTI Nucleoside/-tide comb. Read more about RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides

93 drugs in this class 37 manufacturers

Advertisement

Drugs in RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides

Showing 10–18 of 93 drugs

ZIDOVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION ·+1
GEN-SOURCE RX

ZIDOVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION ·+1
GEN-SOURCE RX
Filter & compare in the drug finder → Opens the drug finder with RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides preselected. Add indication or manufacturer filters there.

About RTI Nucleoside/-tide comb. and other RTI Nucleosides/-tides.

The phrase "RTI Nucleoside/-tide comb.

and other RTI Nucleosides/-tides" is an administrative or formulary classification label rather than a standardized, distinct therapeutic drug class.

Clinically, it refers to nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), encompassing both fixed-dose combination formulations and individual single-agent antiretrovirals.

These pharmacologic agents function as false substrates that compete with natural deoxynucleotides for incorporation into viral DNA, leading to chain termination and inhibition of viral reverse transcriptase activity.

In clinical practice, they serve as foundational backbone components for the management and prevention of human immunodeficiency virus type 1 (HIV-1) infection, with select nucleotide analogs also indicated for the treatment of chronic hepatitis B virus infection.